Mustang Bio, Inc. (MBIO) stock
MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.01 (-2.56%)
Close on Nov 18, 2026Market cap $2.88MP/E –Yield –
Mustang Bio total assets
Total assets on the balance sheet at the end of each period.
Mustang Bio's total assets was $15.61M at Jun 30, 2026. For fiscal 2025 it was $17.59M, up 89.0% from the year before. The highest annual figure on record is $125.17M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.59M | +89.0% |
| FY2024 | Dec 31, 2024 | $9.31M | -47.5% |
| FY2023 | Dec 31, 2023 | $17.74M | -80.8% |
| FY2022 | Dec 31, 2022 | $92.42M | -26.2% |
| FY2021 | Dec 31, 2021 | $125.17M | +13.9% |
| FY2020 | Dec 31, 2020 | $109.90M | +49.6% |
| FY2019 | Dec 31, 2019 | $73.45M | +71.8% |
| FY2018 | Dec 31, 2018 | $42.75M | -32.7% |
| FY2017 | Dec 31, 2017 | $63.49M | +130.9% |
| FY2016 | Dec 31, 2016 | $27.50M | – |
| FY2015 | Dec 31, 2015 | $0 | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $15.61M | +19.7% |
| Q1 FY2026 | Mar 31, 2026 | $16.58M | +11.2% |
| Q4 FY2025 | Dec 31, 2025 | $17.59M | +89.0% |
| Q3 FY2025 | Sep 30, 2025 | $19.36M | +169.2% |
| Q2 FY2025 | Jun 30, 2025 | $13.05M | +53.1% |
| Q1 FY2025 | Mar 31, 2025 | $14.91M | +2.2% |
| Q4 FY2024 | Dec 31, 2024 | $9.31M | -47.5% |
| Q3 FY2024 | Sep 30, 2024 | $7.19M | -65.0% |
| Q2 FY2024 | Jun 30, 2024 | $8.52M | -70.7% |
| Q1 FY2024 | Mar 31, 2024 | $14.59M | -80.2% |
| Q4 FY2023 | Dec 31, 2023 | $17.74M | -80.8% |
| Q3 FY2023 | Sep 30, 2023 | $20.57M | -81.1% |
| Q2 FY2023 | Jun 30, 2023 | $29.09M | -76.1% |
| Q1 FY2023 | Mar 31, 2023 | $73.61M | -46.3% |
| Q4 FY2022 | Dec 31, 2022 | $92.42M | -26.2% |
| Q3 FY2022 | Sep 30, 2022 | $108.84M | -19.2% |
| Q2 FY2022 | Jun 30, 2022 | $121.91M | -14.9% |
| Q1 FY2022 | Mar 31, 2022 | $136.96M | -3.4% |
| Q4 FY2021 | Dec 31, 2021 | $125.17M | +13.9% |
| Q3 FY2021 | Sep 30, 2021 | $134.71M | +56.5% |
| Q2 FY2021 | Jun 30, 2021 | $143.21M | +47.9% |
| Q1 FY2021 | Mar 31, 2021 | $141.82M | +106.9% |
| Q4 FY2020 | Dec 31, 2020 | $109.90M | +49.6% |
| Q3 FY2020 | Sep 30, 2020 | $86.07M | +2.7% |
| Q2 FY2020 | Jun 30, 2020 | $96.83M | +4.5% |
| Q1 FY2020 | Mar 31, 2020 | $68.56M | +35.8% |
| Q4 FY2019 | Dec 31, 2019 | $73.45M | +71.8% |
| Q3 FY2019 | Sep 30, 2019 | $83.84M | +69.3% |
| Q2 FY2019 | Jun 30, 2019 | $92.63M | +66.4% |
| Q1 FY2019 | Mar 31, 2019 | $50.49M | -17.4% |
| Q4 FY2018 | Dec 31, 2018 | $42.75M | -32.7% |
| Q3 FY2018 | Sep 30, 2018 | $49.51M | -27.1% |
| Q2 FY2018 | Jun 30, 2018 | $55.68M | -24.6% |
| Q1 FY2018 | Mar 31, 2018 | $61.09M | -18.6% |
| Q4 FY2017 | Dec 31, 2017 | $63.49M | +130.9% |
| Q3 FY2017 | Sep 30, 2017 | $67.89M | +510.6% |
| Q2 FY2017 | Jun 30, 2017 | $73.84M | – |
| Q1 FY2017 | Mar 31, 2017 | $75.03M | – |
| Q4 FY2016 | Dec 31, 2016 | $27.50M | – |
| Q3 FY2016 | Sep 30, 2016 | $11.12M | – |
See a number that looks wrong?